Harvard-trained physician-scientist and executive coach. Creator of Neuroalignment. Author of ten bestselling books. Inventor. 5× TEDx speaker. Host of the StucktoStrong podcast. Forty-two years spent where focus, alignment, and human resilience decide the outcome.
Dr. Ravi R. Iyer, MD is a Harvard-trained physician-scientist and executive coach, the creator of the Neuroalignment framework, author of ten bestselling books, an inventor, a 5× TEDx speaker, and host of the StucktoStrong podcast. His work follows one question: how do human attention and alignment decide performance — in a person, a team, a leader, and an organization?
Over a 42-year career in medicine and science, Dr. Iyer founded ActivPower Inc., The Iyer Clinic, and IRFocalPoint, and serves as Chief Strategy Officer at Ayora Health. He previously served nine years as a hospice medical director and four years as chairman of the Department of Medicine at a 225-bed hospital, after research fellowships spanning Harvard Medical School, Massachusetts General Hospital, and Boston Children's Hospital. He has written ten bestselling books on leadership, strategy, and human performance, created the Neuroalignment framework for focus and resilience, and holds patents in human and veterinary health. Along the way he learned how teams focus, align, and hold together in the settings where the stakes are highest — at the bedside, in the ICU, and in end-of-life care.
Today he brings that understanding to leaders in four ways: coaching individuals and teams, courses and workshops built on Neuroalignment, writing — ten bestselling books, a business column, and his own essays — and the stage. His TEDxGary talk, “The Power of Intentional Focus,” became the #1 most-viewed TEDx talk of 2024, with more than 4.4 million views. Born in Mumbai and schooled in medicine at Nalanda Medical College on the banks of the Ganges in Patna — where he swam each morning before class — his throughline has stayed constant: human attention and alignment are the raw material of every high-performing team.
Current roles: Founder/CEO, Iyer Health & Nova Health Management & Research Group, PC · Founder/Chairman, ActivPower Inc. · Principal, driyer.com & IRFocalPoint · Chief Strategy Officer, Ayora Health, LLC.
Ways to work with Dr. Iyer →As founding physician of Iyer Health in Northern Virginia, Dr. Iyer leads a clinical team seeing 25–30 patients a day — everyday primary care alongside advanced longevity and regenerative medicine. What he brings to the stage is not drawn from the literature. It is what he relies on to run a practice where the consequences arrive the same week.
Primary care covered by commercial insurance, with same-day appointments: annual physicals, executive wellness exams, screenings, immunizations, and the ongoing management of diabetes, hypertension, cholesterol, thyroid, asthma, and heart disease. One clinic, one record, one team — in English, Tamil, Hindi, or Spanish, spoken by both doctor and staff.
The direct cash-pay program of Iyer Health: longevity, regenerative, functional, and aesthetic medicine: advanced biomarker and cardiometabolic panels, body composition, cardiovascular and cancer risk profiling, hormone and micronutrient work, and physician-administered regenerative therapy. Results feed the Ayora precision-medicine platform, which tracks biological age against chronological age.
Both models sit under one roof by design — as the practice puts it, advanced medicine and accessible medicine belong under the same roof. On a given afternoon that means a Northern Virginia family on a commercial plan, and an executive for whom cost was never the constraint. The same physician. The same standard.
That range is instructive. When a patient can command every intervention available and the honest answer remains sleep, focus, and the discipline to stop overriding your own biology, the conclusion is difficult to avoid: performance is not purchased. It is aligned. Which is the same thing he says on stage — only there, the outcome is a quarter rather than a life.
Dr. Iyer accepted The Outstanding Organization Award for ActivPower Inc. at the Health 2.0 Conference (The 2.0 Conferences, 2026) as its Founder/Chairman — publicized on the Times Square billboard.
The same principles he teaches on stage are what earned ActivPower that recognition — he doesn't just teach them, he leads a company that proves them.
Dr. Iyer believes the next era of performance won't be won by working harder or adding more technology, but by aligning human minds — protecting focus, judgment, and connection as AI reshapes how we work. His neuroalignment frameworks give leaders a practical way to do exactly that.
Tiered biographies (35-word, 80-word, and 150-word) and hi-res photos are in the speaker kit, ready to drop into a program, introduction, or press page.
A factual record of Dr. Ravi R. Iyer's training, clinical research, appointments and scientific publications. Dr. Iyer's structured profile is maintained on Wikidata (Q141280220).
| Years | Training | Institution |
|---|---|---|
| Oct. 1993 – Oct. 1996 | Resident in Internal Medicine | George Washington University Medical Center and Affiliated Hospitals, Washington, DC |
| 1991 – 1993 | Research Fellow in Medicine, Children's Hospital, Boston; Research Fellow in Pediatrics, Harvard Medical School | Boston, MA |
| 1988 – 1991 | Research Fellow in Medicine, Massachusetts General Hospital Cancer Center; Research Fellow in Medicine, Harvard Medical School | Boston, MA |
| 1985 – 1988 | Doctor of Medicine (M.D.) in Biochemistry; degree conferred May 1, 1989 | All India Institute of Medical Sciences, New Delhi |
| Feb. – June 1985 | Junior Resident, Department of Surgery | Nalanda Medical College, Patna, India |
| Feb. 1984 – Feb. 1985 | Rotating internship | Nalanda Medical College, Patna, India |
| 1977 – 1983 | M.B.B.S. (Bachelor of Medicine, Bachelor of Surgery); final examination September 1983 | Nalanda Medical College, Patna (Magadh University), India |
Dr. Ravi R. Iyer has served as Director of Clinical Research of Nova Health Management & Research Group, PC since November 1997, and as Director of Clinical Research of Loudoun Medical Group since October 2022. He has been site principal investigator at the group's Northern Virginia research site for the following industry-sponsored clinical trials.
| Study period | Trial | Condition | Registry | Protocol · Sponsor |
|---|---|---|---|---|
| 2017 – 2022 | PROMINENT (pemafibrate) | Type 2 diabetes, triglycerides, cardiovascular outcomes | NCT03071692 | K-877-302 · Kowa Research Institute |
| 2017 – 2018 | SUSTAIN 8 (semaglutide vs canagliflozin) | Type 2 diabetes | NCT03136484 | NN9535-4270 · Novo Nordisk |
| 2014 – 2020 | STRENGTH (Epanova) | Hypertriglyceridemia, cardiovascular outcomes | NCT02104817 | D5881C00004 · AstraZeneca |
| 2014 – 2016 | RISE (Symbicort pMDI) | COPD exacerbations | NCT02157935 | D589UC00001 · AstraZeneca |
| 2014 – 2018 | LARIAT (bardoxolone methyl) | Pulmonary hypertension | NCT02036970 | RTA 402-C-1302 · Reata / Biogen |
| 2014 – 2015 | Febuxostat XR | Gout with moderate renal impairment | NCT02128490 | FEB-XR_201 · Takeda |
| 2013 – 2015 | CIC3 (plecanatide) | Chronic idiopathic constipation | NCT01982240 | SP304203-00 · Synergy (now Bausch Health) |
| 2013 – 2018 | CARMELINA (linagliptin) | Type 2 diabetes with kidney disease, cardiovascular outcomes | NCT01897532 | 1218.22 · Boehringer Ingelheim |
| 2012 – 2013 | Z160 (post-herpetic neuralgia) | Post-herpetic neuralgia | NCT01757873 | Z160-PHN-202 · Zalicus |
| 2012 – 2017 | Omarigliptin (MK-3102) cardiovascular outcomes | Type 2 diabetes, cardiovascular outcomes | NCT01703208 | MK-3102-018 · Merck Sharp & Dohme |
Current executive roles are listed above under Current roles.
| Years | Position | Organization |
|---|---|---|
| Oct. 2022 – present | Director of Clinical Research | Loudoun Medical Group, Virginia |
| 2018 – present | Clinical Preceptor, Family Nurse Practitioner program | Georgetown University School of Nursing, Washington, DC |
| Nov. 1997 – present | Director of Clinical Research and Principal Investigator | Nova Health Management & Research Group, PC (The Iyer Clinic), Herndon, VA |
| Nov. 15, 2013 – June 30, 2016 | Medical Advisor and Advisory Board Member | The Medical Team, Inc., Reston, VA (home health agency) |
| Oct. 2013 – Apr. 2014 | Facility Physician Leader and Chair, Physician Advisory Group | Reston Hospital Center, Reston, VA |
| 2012 – 2015 | Chairman, Department of Medicine | Reston Hospital Center, Reston, VA |
| 2008 – 2011 | Vice-Chairman, Department of Medicine | Reston Hospital Center, Reston, VA |
| Oct. 2004 – Dec. 2013 | Medical Director | Heartland Hospice, Fairfax, VA |
| 1998 | Clinical Preceptor | George Mason University, College of Nursing and Health Science, Fairfax, VA |
| 1997 – 2000 | Chairman and Director, Research & Development | Predictive Health Care Systems, Inc. |
| 1996 – 1997 | Physician | Practice of Dr. Neeraj Bhushan, MD |
Clinical trial details as listed on ClinicalTrials.gov (checked October 2026). Publication details as indexed by the publishers and PubMed.
Occasional essays from Dr. Iyer on leadership, cognition, and getting the best from people — straight to your inbox. No noise.
Coaching for leaders and teams, courses built on Neuroalignment, or a keynote your people will still be quoting next quarter — start with a conversation.